journal
Journals European Journal of Pharmaceut...

European Journal of Pharmaceutics and Biopharmaceutics

https://read.qxmd.com/read/38537908/development-of-a-simple-paste-for-3d-printing-of-drug-formulations-containing-a-mesoporous-material-loaded-with-a-poorly-water-soluble-drug
#21
JOURNAL ARTICLE
Christos S Katsiotis, Evgenii Tikhomirov, Christos Leliopoulos, Maria Strømme, Ken Welch
Poorly soluble drugs represent a substantial portion of emerging drug candidates, posing significant challenges for pharmaceutical formulators. One promising method to enhance the drug's dissolution rate and, consequently, bioavailability involves transforming them into an amorphous state within mesoporous materials. These materials can then be seamlessly integrated into personalized drug formulations using Additive Manufacturing (AM) techniques, most commonly via Fused Deposition Modeling. Another innovative approach within the realm of AM for mesoporous material-based formulations is semi-solid extrusion (SSE)...
March 25, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38537907/exploring-the-influence-of-microstructure-and-phospholipid-type-of-liposomes-on-their-interaction-with-lung
#22
JOURNAL ARTICLE
Jing Zhao, Ye Yuan, Jingwen Xue, Anyue Hou, Shimeng Song, Jian Guan, Xin Zhang, Shirui Mao
Liposome is a promising carrier for pulmonary drug delivery and the nano-sized liposomes have been widely investigated in the treatment of lung diseases. However, there still lack the knowledge of micron-sized liposomes for lung delivery, which have more advantages in terms of drug loading and sustained drug release capacity. The micron-sized liposomes can be classified into multilamellar liposome (MLL) and multivesicular liposome (MVL) according to their microstructure, thus, this study focused on exploring how the micron-sized liposomes with different microstructure and phospholipid composition influence their interaction with the lung...
March 25, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38527635/sucrose-ester-embedded-lipid-carrier-for-dna-delivery
#23
JOURNAL ARTICLE
Yinan Zhao, Wanting Ma, Kexin Tian, Zhe Wang, Xingxing Fu, Qi Zuo, Yanfei Qi, Shubiao Zhang
Sucrose esters (SEs) have great potential in the field of nucleic acid delivery due to their unique physical and chemical properties and good biosafety. However, the mechanism of the effect of SEs structure on delivery efficiency has not been studied. The liposomes containing peptide lipids and SEs were constructed, and the effects of SEs on the interaction between the liposomes and DNA were studied. The addition of SEs affects the binding rate of liposomes to DNA, and the binding rate gradually decreases with the increase of SEs' carbon chain length...
March 23, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38521661/corrigendum-to-sequentially-dynamic-polymeric-micelles-with-detachable-pegylation-for-enhanced-chemotherapeutic-efficacy-eur-j-pharm-biopharm-145-2019-54-64
#24
Guoqing Yan, Yan Huang, Dapeng Li, Yong Xu, Jun Wang, Xin Wang, Rupei Tang
No abstract text is available yet for this article.
March 22, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38514020/exploring-the-potential-of-p-glycoprotein-inhibitors-in-the-targeted-delivery-of-anti-cancer-drugs-a-comprehensive-review
#25
REVIEW
Dhvani Patel, Nutan Sethi, Paresh Patel, Shreeraj Shah, Kaushika Patel
Due to the high prevalence of cancer, progress in the management of cancer is the need of the hour. Most cancer patients develop chemotherapeutic drug resistance, and many remain insidious due to overexpression of Multidrug Resistance Protein 1 (MDR1), also known as Permeability-glycoprotein (P-gp) or ABCB1 transporter (ATP-binding cassette subfamily B member 1). P-gp, a transmembrane protein that protects vital organs from outside chemicals, expels medications from malignant cells. The blood-brain barrier (BBB), gastrointestinal tract (GIT), kidneys, liver, pancreas, and cancer cells overexpress P-gp on their apical surfaces, making treatment inefficient and resistant...
March 19, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38499255/lipid-nanoparticles-for-local-delivery-of-mrna-to-the-respiratory-tract-effect-of-peg-lipid-content-and-administration-route
#26
JOURNAL ARTICLE
Melike Ongun, Abhijeet Girish Lokras, Saahil Baghel, Zhenning Shi, Signe Tandrup Schmidt, Henrik Franzyk, Thomas Rades, Federica Sebastiani, Aneesh Thakur, Camilla Foged
Design of inhalable mRNA therapeutics is promising, because local administration in the respiratory tract is minimally invasive and induces a local response. However, several challenges related to administration via inhalation and respiratory tract barriers have so far prevented the progress of inhaled mRNA therapeutics. Here, we investigated factors of importance for lipid nanoparticle (LNP)-mediated delivery of mRNA to the respiratory tract. We hypothesized that: (i) the PEG-lipid content is important for providing colloidal stability during aerosolization and for mucosal delivery, (ii) the PEG-lipid contentinfluences mRNA expression in the lungs, and (iii) the route of administration (nasal versus pulmonary) influences mRNA expression in the lungs...
March 16, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38492868/meta-analysis-guided-development-of-a-standard-artificial-urine
#27
JOURNAL ARTICLE
Kimberley A Noble, Hayley K Y Chan, Oisín N Kavanagh
In this study, we present the first meta-analysis of human urine reported in the literature, drawing data from a total of 35 articles with a combined participant count of 14,021. Through this analysis, we have developed an artificial urine (AU) composition that can be adjusted within typical physiological parameters for in vitro applications. Our findings demonstrate the utility of this AU in determining the solubility of nitrofurantoin, particularly in the context of crystalluria. Notably, we observe that in saline, nitrofurantoin solubility, within the framework of its urinary pharmacokinetics, suggests a risk of crystalluria...
March 14, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38492867/don-t-shake-it-mechanical-stress-testing-of-mrna-lipid-nanoparticles
#28
JOURNAL ARTICLE
Anna Ruppl, Denis Kiesewetter, Franziska Strütt, Monika Köll-Weber, Regine Süss, Andrea Allmendinger
Shaking stress studies are typically performed during formulation development to test the liability of a drug product towards interfacial stress occurring during transport, especially if a liquid formulation is desired. We evaluated various shaking procedures using a polyA-surrogate solution and verified our findings by eGFP-LNP cell-expression experiments. Shaking on an orbital shaker in vertical and horizontal orientations at increasing speeds from 300 to 600 rpm resulted in decreasing levels of encapsulated nucleic acid content, larger LNP sizes, and decreasing PDI...
March 14, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38490349/reducing-hydrophobic-drug-adsorption-in-an-in-vitro-extracorporeal-membrane-oxygenation-model
#29
JOURNAL ARTICLE
Nitish Khurana, Kamiya Watkins, Debika Ghatak, Jane Staples, Oliver Hubbard, Venkata Yellepeddi, Kevin Watt, Hamidreza Ghandehari
Extracorporeal membrane oxygenation (ECMO) is a life-saving cardiopulmonary bypass technology for critically ill patients with heart and lung failure. Patients treated with ECMO receive a range of drugs that are used to treat underlying diseases and critical illnesses. However, the dosing guidelines for these drugs used in ECMO patients are unclear. Mortality rate for patients on ECMO exceeds 40% partly due to inaccurate dosing information, caused in part by the adsorption of drugs in the ECMO circuit and its components...
March 13, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38484852/comprehensive-ocular-and-systemic-pharmacokinetics-of-dexamethasone-after-subconjunctival-and-intravenous-injections-in-rabbits
#30
JOURNAL ARTICLE
Annika Valtari, Susanna Posio, Elisa Toropainen, Anusha Balla, Jooseppi Puranen, Amir Sadeghi, Marika Ruponen, Veli-Pekka Ranta, Kati-Sisko Vellonen, Arto Urtti, Eva M Del Amo
Even though subconjunctival injections are used in clinics, their quantitative pharmacokinetics has not been studied systematically. For this purpose, we evaluated the ocular and plasma pharmacokinetics of subconjunctival dexamethasone in rabbits. Intravenous injection was also given to enable a better understanding of the systemic pharmacokinetics. Dexamethasone concentrations in plasma (after subconjunctival and intravenous injections) and four ocular tissues (iris-ciliary body, aqueous humour, neural retina and vitreous) were analysed using LC-MS/MS...
March 12, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38479564/phototoxicity-in-vitro-and-safety-in-vivo-of-the-emulsion-photosensitizer-based-on-furanocoumarins-of-heracleum-sosnowskyi
#31
JOURNAL ARTICLE
Oleg A Kulikov, Vasilisa I Shlyapkina, Ekaterina P Brodovskaya, Amina M Al-Khadj Aioub, Valentin P Ageev, Mikhail N Zharkov, Denis E Yakobson, Daniil S Sokushev, Nikolay A Pyataev, Gleb B Sukhorukov
The use of plants such as giant hogweed as raw materials for the manufacture of dosage forms has been little explored. In this study, we utilized furanocoumarins from the Heracleum sosnowskyi plant to create an experimental emulsion dosage form (EmFHS). The EmFHS was finely dispersed (481.8 nm ± 71.1 nm), shelf-stable, and contained predominantly 8-methoxypsoralen at a concentration of 1 mg/ml. Phototoxicity analysis of EmFHS for THP-1 cells under UV (365 nm) irradiation showed an IC50 of 19...
March 11, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38479563/synthesis-of-folate-targeted-theranostic-cubosomal-platform-for-co-delivery-of-bismuth-oxide-and-doxorubicin-to-melanoma-in-vitro-and-in-vivo
#32
JOURNAL ARTICLE
Mahsa Zahiri, Hosein Kamali, Khalil Abnous, Seyed Mohammad Taghdisi, Sirous Nekooei, Negar Nekooei, Mohammad Ramezani, Mona Alibolandi
Liquid crystalline nanoparticles (LCNPs) have gained much attention in cancer nanomedicines due to their unique features such as high surface area, storage stability, and sustained-release profile. In the current study, a novel LCNP for co-encapsulation of Bi2 O3 and hydrophilic doxorubicin (DOX) was fabricated and functionalized with folic acid (FA) to achieve efficient tumor targeting toward CT-scan imaging and chemotherapy of melanoma in vitro and in vivo. LCNPs Bi2 O3 NPs were prepared using glycerol monooleate-pluronic F-127 (GMO/PF127/water)...
March 11, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38479562/recent-advances-of-ultrasound-responsive-nanosystems-in-tumor-immunotherapy
#33
REVIEW
Penghui Wang, Ji Chen, Runming Zhong, Yuanyuan Xia, Zhina Wu, Chunye Zhang, Hai Yao
Immunotherapy has revolutionized cancer treatment by boosting the immune system and preventing disease escape mechanisms. Despite its potential, challenges like limited response rates and adverse immune effects impede its widespread clinical adoption. Ultrasound (US), known for its safety and effectiveness in tumor diagnosis and therapy, has been shown to significantly enhance immunotherapy when used with nanosystems. High-intensity focused ultrasound (HIFU) can obliterate tumor cells and elicit immune reactions through the creation of immunogenic debris...
March 11, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38479561/phage-based-antibacterial-hydrogels-for-bacterial-targeting-and-ablation-progress-and-perspective
#34
REVIEW
Haoran Bai, Qinggele Borjihan, Zheng Li, Peiran Qin, Jingli Cheng, Douxin Xiao, Alideertu Dong
The emergence of drug-resistant bacteria makes antibiotics inadequate to treat bacterial infections, which is now a global problem. Phage as a virus with specific recognition ability can effectively kill the bacteria, which is an efficacious antibacterial material to replace antibiotics. Phage-based hydrogels have good biocompatibility and antibacterial effect at the site of infection. Phage hydrogels have remarkable antibacterial effects on targeted bacteria because of their specific targeted bactericidal ability, but there are few reports and reviews on phage hydrogels...
March 11, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38467336/antimicrobial-peptide-a-9-k-as-a-gene-delivery-vector-in-cancer-cells
#35
JOURNAL ARTICLE
Silvia Cirillo, Bo Zhang, Stephen Brown, Xiubo Zhao
Designed peptides are promising biomaterials for biomedical applications. The amphiphilic cationic antimicrobial peptide (AMP), A9 K, can self-assemble into nano-rod structures and has shown cancer cell selectivity and could therefore be a promising candidate for therapeutic delivery into cancer cells. In this paper, we investigate the selectivity of A9 K for cancer cell models, examining its effect on two human cancer cell lines, A431 and HCT-116. Little or no activity was instead observed on the control, human dermal fibroblasts (HDFs)...
March 9, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38467335/identification-of-structural-origins-of-complex-charge-heterogeneity-in-therapeutic-ace2fc-fusion-protein-facilitated-by-free-flow-isoelectric-focusing
#36
JOURNAL ARTICLE
Lingyu Wang, Hai Wu, Ting Cao, Hongyang Li, Pengcheng Shen, Lihong Lu, Zhongli Zhang
Fc Fusion protein represents a versatile molecular platform with considerable potential as protein therapeutics of which the charge heterogeneity should be well characterized according to regulatory guidelines. Angiotensin-converting enzyme 2 Fc fusion protein (ACE2Fc) has been investigated as a potential neutralizing agent to various coronaviruses, including the lingering SARS-CoV-2, as this coronavirus must bind to ACE2 to allow for its entry into host cells. ACE2Fc, an investigational new drug developed by Henlius (Shanghai China), has passed the Phase I clinical trial, but its huge amount of charge isoforms and complicated charge heterogeneity posed a challenge to charge variant investigation in pharmaceutical development...
March 9, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38467334/cyclodextrin-microneedles-for-the-delivery-of-a-nanoparticle-based-peptide-antigen-vaccine
#37
JOURNAL ARTICLE
Silvana Geisshüsler, Frida Nilsson, Nicole Ziak, Zuzanna Kotkowska, Marta Paolucci, Marina Green Buzhor, Nicole Zoratto, Pål Johansen, Jean-Christophe Leroux
In recent years, microneedles (MNs) have gained considerable interest in drug formulation due to their non-invasive and patient-friendly nature. Dissolving MNs have emerged as a promising approach to enhance drug delivery across the skin in a painless manner without generating sharp waste and providing the possibility for self-administration. Cyclodextrins, a group of cyclic oligosaccharides, are well-established in pharmaceutical products due to their safety and unique ability to form inclusion complexes with various drug molecules...
March 9, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38462138/effect-of-in-vitro-transcription-conditions-on-yield-of-high-quality-messenger-and-self-amplifying-rna
#38
JOURNAL ARTICLE
Petya G Popova, Melissa A Lagace, George Tang, Anna K Blakney
Messenger RNA (mRNA) and self-amplifying RNA (saRNA) vaccines against SARS-CoV-2 produced using in vitro transcription (IVT) were clinically approved in 2020 and 2022, respectively. While the industrial production of mRNA using IVT has been extensively optimized, the optimal conditions for saRNA have been explored to a lesser extent. Most T7 polymerase IVT protocols have been specifically optimized for mRNA which is ∼5-10-fold smaller than saRNA and may have profound effects on both the quality and yield of longer transcripts...
March 8, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38458266/toward-the-boosted-loading-of-cisplatin-drug-into-liposome-nanocarriers
#39
JOURNAL ARTICLE
Anna M Wróblewska, Ewelina Łukawska, Zuzanna Wakuła, Joanna Zajda, Bernhard K Keppler, Andrei R Timerbaev, Magdalena Matczuk
Current challenges in oncology are largely associated with the need to improve the effectiveness of cancer treatment and to reduce drug's side effects. An effective strategy to cope with these challenges is behind designing and developing drug delivery systems based on smart nanomaterials and approved anticancer drugs. The present study offers a novel and straightforward approach to efficiently load the cisplatin drug into the newly constructed liposome-based nanosystems as well a reliable technique for monitoring this process based on capillary electrophoresis hyphenated with inductively coupled plasma tandem mass spectrometry...
March 6, 2024: European Journal of Pharmaceutics and Biopharmaceutics
https://read.qxmd.com/read/38452907/preparation-of-etoposide-liposomes-for-enhancing-antitumor-efficacy-on-small-cell-lung-cancer-and-reducing-hematotoxicity-of-drugs
#40
JOURNAL ARTICLE
Ruixue Huang, Huali Chen, Damao Pi, Xuemei He, Chao Yu, Chaoqun Yu
Etoposide (VP-16) is commonly used in the treatment of small cell lung cancer (SCLC) in clinical practice. However, severe adverse reactions such as bone marrow suppression toxicity limit its clinical application. Although several studies on VP16 liposomes were reported, no significant improvement in bone marrow suppression toxicity has been found, and there was a lack of validation of animal models for in vivo antitumor effects. Therefore, we attempted to develop a PEGylated liposomal formulation that effectively encapsulated VP16 (VP16-LPs) and evaluated its therapeutic effect and toxicity at the cellular level and in animal models...
March 5, 2024: European Journal of Pharmaceutics and Biopharmaceutics
journal
journal
30788
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.